Followers | 144 |
Posts | 27709 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Thursday, January 21, 2021 10:56:11 AM
https://finance.yahoo.com/news/biomica-announces-participation-crohns-colitis-120000655.html
Thu, January 21, 2021, 2:00 PM
REHOVOT, Israel, Jan. 21, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), today announced it will be featured as a presenting company at the Crohn's & Colitis Congress® to be held from today January 21-24, 2021.
Prof. Yehuda Ringel, CSO of Biomica, will present "BMC322 - A rationally-designed live bacterial consortium based on microbiome functional genomic analysis for treatment of IBD" on Saturday 23rd January, 2021 at 2PM (EST).
The Crohn's & Colitis Congress is jointly organized by the American Crohn's & Colitis Foundation (CCFA) and the American Gastroenterological Association (AGA). The Congress connects IBD providers and researchers from around the world and will be held virtually this year.
Prof. Ringel will present and discuss the development of Biomica's two rationally-designed live bacterial consortia (BMC322 & BMC321) for treatment of inflammatory bowel disorders (IBD), and preliminary results of a study using BMC322 and BMC321 in animal model of IBD. The abstract was selected with distinction; scored in the top 10% of abstracts chosen for poster presentation.
For details on the conference see: https://crohnscolitiscongress.org/
About Biomica:
Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing a dedicated Computational Predictive Biology platform (CPB), licensed from Evogene. Biomica aims to identify and characterize disease-related microbiome entities and to develop novel therapeutics based on these understandings. The company is focused on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. Biomica is a subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN). For more information, please visit www.biomicamed.com.
Recent EVGN News
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 09/19/2024 08:15:06 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/17/2024 11:00:12 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/16/2024 08:01:22 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 09/04/2024 11:00:07 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/26/2024 01:30:23 PM
- Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement • PR Newswire (US) • 08/23/2024 12:55:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/23/2024 12:50:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/22/2024 11:00:28 AM
- Evogene Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/22/2024 11:00:00 AM
- Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule • PR Newswire (US) • 08/12/2024 11:11:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/12/2024 11:01:49 AM
- Evogene Schedules Second Quarter 2024 Financial Results Release • PR Newswire (US) • 08/12/2024 11:00:00 AM
- Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil • PR Newswire (US) • 07/31/2024 11:00:00 AM
- Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split • PR Newswire (US) • 07/23/2024 12:48:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/23/2024 11:00:10 AM
- ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants • PR Newswire (US) • 07/17/2024 12:00:00 PM
- Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat • PR Newswire (US) • 07/02/2024 11:00:00 AM
- Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country • PR Newswire (US) • 06/25/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/17/2024 08:10:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/06/2024 08:02:44 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/23/2024 03:00:08 PM
- Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma • PR Newswire (US) • 05/23/2024 03:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/23/2024 11:00:23 AM
- Evogene Reports First Quarter 2024 Financial Results • PR Newswire (US) • 05/23/2024 11:00:00 AM
- Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds • PR Newswire (US) • 05/21/2024 11:03:00 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM